Transgender hormone therapy (male-to-female) rare cases of liver damage and lung disease however. Nonsteroidal antiandrogens like bicalutamide may be a particularly favorable option for transgender women who wish to preserve sex drive, sexual function, and/or fertility, relative to antiandrogens that suppress testosterone levels and can greatly disrupt these functions like cyproterone acetate and GnRH modulators. GnRH modulators are powerful antigonadotropins and hence functional antiandrogens. In both males and females, gonadotropin-releasing hormone (GnRH) is produced in the hypothalamus and induces the secretion of the gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. The gonadotropins signal the gonads to make sex hormones
Sexual desire and intimate relationships primary goal of sexual desire. It has also been suggested that women are more likely than men to develop a “relational” or “person-centered” orientation to sexual desire, whereas men are more likely to adopt a “recreational” or “body-centered” orientation to sexuality. These results further support the suggestion that despite generally consistent definitions of sexual desire, perceived differing end goals of sexual desire may exist between the sexes. In keeping with providing definitions of sexual desire consistent with those of theorists, both men and women have consistently expressed their beliefs that the causes of male sexual desire differ from female causes